(4R)-3,4-DIMETHYL-1,3-OXAZOLIDINE-2,5-DIONE

(4R)-3,4-DIMETHYL-1,3-OXAZOLIDINE-2,5-DIONE Struktur
91049-52-4
CAS-Nr.
91049-52-4
Englisch Name:
(4R)-3,4-DIMETHYL-1,3-OXAZOLIDINE-2,5-DIONE
Synonyma:
(R)-3,4-Dimethyloxazolidine-2,5-dione;2,5-Oxazolidinedione, 3,4-dimethyl-, (R)-;2,5-Oxazolidinedione, 3,4-dimethyl-, (4R)-;(4R)-3,4-DIMETHYL-1,3-OXAZOLIDINE-2,5-DIONE
CBNumber:
CB13875954
Summenformel:
C5H7NO3
Molgewicht:
129.11
MOL-Datei:
91049-52-4.mol

(4R)-3,4-DIMETHYL-1,3-OXAZOLIDINE-2,5-DIONE Eigenschaften

Sicherheit

(4R)-3,4-DIMETHYL-1,3-OXAZOLIDINE-2,5-DIONE Chemische Eigenschaften,Einsatz,Produktion Methoden

(4R)-3,4-DIMETHYL-1,3-OXAZOLIDINE-2,5-DIONE Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


(4R)-3,4-DIMETHYL-1,3-OXAZOLIDINE-2,5-DIONE Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 11)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Suzhou ARTK Medchem Co., Ltd.
+86-512-68323658 +86-18168183658
sales1@artkmedchem.com China 39004 58
Shanghai GaoDao Pharmaceutical Co., Ltd. 021-15001867143 15001867143
1095570358@qq.com China 783 55
Shanghai Wishpharma Co.,Ltd. 021-56789108 18694901298
95413064@qq.com China 260 56
Shanghai Qitong Pharmaceutical Technology Co., Ltd. 18918399319 18918399319
24907461@qq.com China 253 58
Taizhou Nanfeng Pharmaceutical Research Institute 18616377689
nanfengdrug@163.com China 20565 58
Shanghai Haohong Pharmaceutical Co., Ltd. 4008210725 4008210725
malulu@leyan.com China 54986 58
Shanghai Sunway Pharmaceutical Technology Co.,Ltd. 021-51816796-820 13611835272
sales2@sunwaypharm.com China 44458 58
PharmaBlock Sciences (Nanjing), Inc. 4000255188 4000255188
sales_china@pharmablock.com China 9786 58
Bide Pharmatech Ltd. 400-1647117 13681763483
product02@bidepharm.com China 62163 58

  • (4R)-3,4-DIMETHYL-1,3-OXAZOLIDINE-2,5-DIONE
  • 2,5-Oxazolidinedione, 3,4-dimethyl-, (R)-
  • (R)-3,4-Dimethyloxazolidine-2,5-dione
  • 2,5-Oxazolidinedione, 3,4-dimethyl-, (4R)-
  • 91049-52-4
Copyright 2019 © ChemicalBook. All rights reserved